IE |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human IE cells after 72 hrs by trypan blue exclusion assay, EC50 = 1.46 μM. |
19674905 |
SVCT-M12 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human SVCT-M12 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.96 μM. |
19674905 |
MCF7 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MCF7 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.96 μM. |
19674905 |
Hs888Lu |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human Hs888Lu cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.56 μM. |
19674905 |
A549 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human A549 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.43 μM. |
19674905 |
PC3 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human PC3 cells after 72 hrs by trypan blue exclusion assay, EC50 = 0.14 μM. |
19674905 |
SMMC7721 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human SMMC7721 cells after 48 hrs by SRB assay, IC50 = 5.4 μM. |
19432411 |
HeLa |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 3.3 μM. |
19432411 |
HL60 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HL60 cells after 48 hrs by SRB assay, IC50 = 1.5 μM. |
19432411 |
HCT8 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HCT8 cells after 72 hrs by SRB assay, IC90 = 5.7 μM. |
18845441 |
HCT8 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HCT8 cells after 72 hrs by SRB assay, IC50 = 0.083 μM. |
18845441 |
A549 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human A549 cells after 72 hrs by Alamar Blue assay, IC50 = 0.4 μM. |
18752870 |
MCF7 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human MCF7 cells after 72 hrs by Alamar Blue assay, IC50 = 0.2 μM. |
18752870 |
BAC29 |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against BRCA2-proficient Chinese hamster BAC29 mutant cells after 3 days by WST1 cell viability assay, IC50 = 0.4 μM. |
18505284 |
V-C8 |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against BRCA2-deficient Chinese hamster V-C8 mutant cells after 3 days by WST1 cell viability assay, IC50 = 0.005 μM. |
18505284 |
HT29 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HT29 cells after 72 hrs by MTT assay in presence of 2 uM dicoumarol, IC50 = 2.1 μM. |
18222567 |
HT29 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HT29 cells after 72 hrs by MTT assay, IC50 = 0.9 μM. |
18222567 |
MCF7 |
Cytotoxicity assay |
|
24 hrs |
Cytotoxicity against human MCF7 cells after 24 hrs, IC50 = 5 μM. |
18037301 |
A549 |
Cytotoxicity assay |
|
24 hrs |
Cytotoxicity against human A549 cells after 24 hrs, IC50 = 4.5 μM. |
18037301 |
MCF7 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human MCF7 cells after 72 hrs, IC50 = 1.2 μM. |
18037301 |
A549 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human A549 cells after 72 hrs, IC50 = 0.24 μM. |
18037301 |
MCF7 |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against human MCF7 cells after 3 days by SRB assay, IC50 = 1.5 μM. |
16038545 |
HCT8 |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against human HCT8 cells after 3 days by SRB assay, IC50 = 0.6 μM. |
16038545 |
KB |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against human KB cells after 3 days by SRB assay, IC50 = 0.6 μM. |
16038545 |
A549 |
Cytotoxicity assay |
|
3 days |
Cytotoxicity against human A549 cells after 3 days by SRB assay, IC50 = 0.3 μM. |
16038545 |
HeLa |
Cytotoxicity assay |
|
5 to 8 days |
Cytotoxicity against human HeLa cells assessed as inhibition of colony formation after 5 to 8 days by colony assay, IC50 = 0.068 μM. |
11975488 |
EMT6 |
Function assay |
|
1 hr |
Compound is measured for surviving fractions of EMT6 tumor cells treated in culture with (0.50 uM) concentration for 1 hr under aerobic condition., ED50 = 0.7 μM. |
7452674 |
EMT6 |
Function assay |
|
1 hr |
Compound is measured for surviving fractions of EMT6 tumor cells treated in culture with (0.50 uM) concentration for 1 hr under hypoxic condition., ED50 = 0.001 μM. |
7452674 |
L1210 |
Growth inhibition assay |
|
1 hr |
Inhibition of L1210 leukemia cells, after exposure to compound for period of 1 hr, ID50 = 3.1 μM. |
3397995 |
L1210 |
Growth inhibition assay |
|
8-9 hrs |
Inhibition of L1210 leukemia cells, after exposure to compound for period of 8-9 hr, ID50 = 0.18 μM. |
3397995 |
AA8 |
Function assay |
|
4 hrs |
Inhibitory activity of compound for AA8 cells to reduce cell density by 50% (exposed to compound for 4 hours), IC50 = 0.00108 μM. |
2909741 |
P388 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay, IC50 = 3 μM. |
2778449 |
HT-29 |
Antiproliferative assay |
|
96 hrs |
Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay, IC50 = 0.099 μM. |
2778449 |
Human Caki-1 Renal CellCarcinoma Cell |
Function assay |
|
96 h |
Inhibitory concentration against Human Caki-1 Renal CellCarcinoma Cell Lines (CD70+) at 96th hour, ic50=40 nM |
15743178 |
human colon cancer cell line HCT15 |
Cytotoxic?assay |
|
72 h |
In vitro cytotoxic activity against human colon cancer cell line HCT15 after 72 hr of drug exposure determined by the SRB assay, IC50=70 nM |
14980672 |
MPC5 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MPC5 cells after 72 hrs by trypan blue exclusion assay, EC50 = 2.1 μM. |
19674905 |
PC3 |
Growth inhibition assay |
|
48 hrs |
Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay, IC50 = 1.5 μM. |
19939522 |
Hep2 |
Growth inhibition assay |
|
48 hrs |
Growth inhibition of human Hep2 cells after 48 hrs by sulforhodamine B assay, IC50 = 1.5 μM. |
19939522 |
Daudi |
Growth inhibition assay |
|
24 to 72 hrs |
Growth inhibition of human Daudi cells after 24 to 72 hrs by MTT assay, IC50 = 0.45 μM. |
20117936 |
K562 |
Growth inhibition assay |
|
24 to 72 hrs |
Growth inhibition of human K562 cells after 24 to 72 hrs by MTT assay, IC50 = 0.47 μM. |
20117936 |
K562-Lucena 1 |
Growth inhibition assay |
|
24 to 72 hrs |
Growth inhibition of human K562-Lucena 1 cells after 24 to 72 hrs by MTT assay, IC50 = 2.75 μM. |
20117936 |
PBMC |
Growth inhibition assay |
|
24 to 72 hrs |
Growth inhibition of phytohemagglutinin-activated human PBMC cells after 24 to 72 hrs by MTT assay, IC50 = 4.03 μM. |
20117936 |
GM00637 |
Cytotoxicity assay |
|
24 hrs |
Cytotoxicity against human GM00637 cells after 24 hrs by MTT assay, IC50 = 0.9 μM. |
20122765 |
DU145 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay, IC50 = 0.17 μM. |
20605274 |
HeLa |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay, IC50 = 0.27 μM. |
20605274 |
GM00637 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human GM00637 cells after 72 hrs by MTT assay, IC50 = 0.46 μM. |
20605274 |
DU145 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human DU145 cells assessed as reduction in mean cell viability after 72 hrs by MTT assay, IC50 = 0.17 μM. |
22522008 |
HeLa |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HeLa cells assessed as reduction in mean cell viability after 72 hrs by MTT assay, IC50 = 0.27 μM. |
22522008 |
GM00637 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human GM00637 cells assessed as reduction in mean cell viability after 72 hrs by MTT assay, IC50 = 0.46 μM. |
22522008 |
HL60 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HL60 cells after 72 hrs by WST8 assay, IC50 = 0.1 μM. |
22537363 |
HL60 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HL60 cells after 48 hrs by SRB assay, IC50 = 1.8 μM. |
22642381 |
HeLa |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 3.4 μM. |
22642381 |
SMMC7721 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human SMMC7721 cells after 48 hrs by SRB assay, IC50 = 5.6 μM. |
22642381 |
A549 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay, IC50 = 0.4 μM. |
23123017 |
HCT116 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HCT116 cells after 48 hrs by sulforhodamine B assay, IC50 = 0.5 μM. |
23501113 |
NCI-H23 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human NCI-H23 cells after 48 hrs by MTT assay, IC50 = 2 μM. |
23792352 |
SPCA1 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human SPCA1 cells after 48 hrs by MTT assay, IC50 = 1.68 μM. |
23999045 |
SGC7901 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay, IC50 = 2.05 μM. |
23999045 |
PC3 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human PC3 cells after 48 hrs by SRB assay, IC50 = 1.5 μM. |
24056146 |
HeLa |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 2 μM. |
24056146 |
MDA-MB-231 |
Cytotoxicity assay |
|
5 days |
Cytotoxicity against human MDA-MB-231 cells overexpressing DT-diaphorase after 5 days, EC50 = 0.103 μM. |
24436995 |
MDA-MB-231 |
Cytotoxicity assay |
|
5 days |
Cytotoxicity against wild-type human MDA-MB-231 cells after 5 days, EC50 = 1.25 μM. |
24436995 |
HCT15 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay, IC50 = 0.5 μM. |
24910974 |
HeLa |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HeLa cells after 48 hrs by SRB method, IC50 = 3 μM. |
24913558 |
SMMC-7221 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human SMMC-7221 cells after 48 hrs by SRB method, IC50 = 3 μM. |
24913558 |
HL60 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HL60 cells after 48 hrs by SRB method, IC50 = 3 μM. |
24913558 |
PC3 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human PC3 cells after 48 hrs by SRB assay, IC50 = 1.5 μM. |
25176329 |
HeLa |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HeLa cells after 48 hrs by SRB assay, IC50 = 2 μM. |
25176329 |
A549 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human A549 cells after 48 hrs by SRB assay, IC50 = 0.04 μM. |
25259515 |
THP1 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human THP1 cells after 48 hrs by SRB assay, IC50 = 0.1 μM. |
25259515 |
MCF7 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay, IC50 = 0.2 μM. |
25259515 |
A549 |
Cytotoxicity assay |
|
24 hrs |
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 24 hrs by WST8 assay, IC50 = 0.45 μM. |
25442306 |
SF539 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SF539 cells after 72 hrs by MTS assay, IC50 = 0.038 μM. |
26335269 |
M14 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human M14 cells after 72 hrs by MTS assay, IC50 = 0.47 μM. |
26335269 |
MDA-MB-468 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human MDA-MB-468 cells after 72 hrs by MTS assay, IC50 = 0.5 μM. |
26335269 |
SF295 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human SF295 cells after 72 hrs by MTS assay, IC50 = 0.54 μM. |
26335269 |
NCI-H226 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human NCI-H226 cells after 72 hrs by MTS assay, IC50 = 0.58 μM. |
26335269 |
A549 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human A549 cells assessed as decrease in cell viability at 10 to 100 uM after 48 hrs by SRB assay, EC50 = 5.2 μM. |
26508550 |
HUT78 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HUT78 cells after 48 hrs by resazurin reduction assay, IC50 = 0.066 μM. |
26541587 |
Jurkat T |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human Jurkat T cells in hypoxic condition after 48 hrs by resazurin reduction assay, IC50 = 0.303 μM. |
26541587 |
HL60 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HL60 cells after 48 hrs by resazurin reduction assay, IC50 = 0.41 μM. |
26541587 |
Jurkat T |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human Jurkat T cells after 48 hrs by resazurin reduction assay, IC50 = 0.578 μM. |
26541587 |
HeLa |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HeLa cells after 48 hrs by resazurin reduction assay, IC50 = 1.87 μM. |
26541587 |
HepG2 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HepG2 cells after 48 hrs by resazurin reduction assay, IC50 = 2.937 μM. |
26541587 |
T47D |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human T47D cells after 48 hrs by resazurin reduction assay, IC50 = 16.97 μM. |
26541587 |
PC3 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human PC3 cells after 72 hrs by CCK-8 assay, IC50 = 1.4 μM. |
26615890 |
A549 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human A549 cells after 72 hrs by CCK-8 assay, IC50 = 1.7 μM. |
26615890 |
HT-29 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HT-29 cells expressing NQO1 after 72 hrs by MTT assay, IC50 = 7.099 μM. |
28395199 |
NCI-H596 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against NQO1 deficient human NCI-H596 cells after 72 hrs by MTT assay, IC50 = 11.969 μM. |
28395199 |
A549 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human A549 cells expressing NQO1 after 72 hrs by MTT assay, IC50 = 15.525 μM. |
28395199 |
LO2 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human LO2 cells after 72 hrs by MTT assay, IC50 = 25.023 μM. |
28395199 |
CHOK1 |
Cytotoxicity assay |
|
24 hrs |
Cytotoxicity against CHOK1 cells incubated for 24 hrs by MTT asasy, IC50 = 13.2 μM. |
28615134 |
A549 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human A549 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.08 μM. |
28682609 |
SKOV3 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human SKOV3 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.1 μM. |
28682609 |
HCT116 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human HCT116 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.2 μM. |
28682609 |
786-O |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human 786-O cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.21 μM. |
28682609 |
BxPC3 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human BxPC3 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 0.38 μM. |
28682609 |
HEC6 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human HEC6 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 1.4 μM. |
28682609 |
MKN74 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human MKN74 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 1.7 μM. |
28682609 |
U87MG |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human U87MG cells after 72 hrs by Cell-Titer Glo assay, GI50 = 1.8 μM. |
28682609 |
HuH7 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human HuH7 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 2 μM. |
28682609 |
MCF7 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human MCF7 cells after 72 hrs by Cell-Titer Glo assay, GI50 = 2.5 μM. |
28682609 |
MDA-MB-231 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay, IC50 = 4.4 μM. |
29280632 |
HL60 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HL60 cells after 48 hrs by CCK8 assay, IC50 = 0.19 μM. |
29475587 |
HeLa |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HeLa cells after 48 hrs by CCK8 assay, IC50 = 1.13 μM. |
29475587 |
Daoy |
Cytotoxicity assay |
|
|
Cytotoxicity against human Daoy cells by MTT assay, ED50 = 0.21 μM. |
19061391 |
WiDr |
Cytotoxicity assay |
|
|
Cytotoxicity against human WiDr cells by MTT assay, ED50 = 0.18 μM. |
19061391 |
A549 |
Cytotoxicity assay |
|
|
Cytotoxicity against human A549 cells by Alamar blue assay, IC50 = 0.4 μM. |
18037301 |
MCF7 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MCF7 cells by Alamar blue assay, IC50 = 0.2 μM. |
18037301 |
MPC5 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MPC5 cells assessed as cell viability by tryptan blue staining method, EC50 = 2.1 μM. |
17950604 |
IE |
Cytotoxicity assay |
|
|
Cytotoxicity against human IE cells assessed as cell viability by tryptan blue staining method, EC50 = 1.46 μM. |
17950604 |
Hc |
Cytotoxicity assay |
|
|
Cytotoxicity against human Hc cells assessed as cell viability by tryptan blue staining method, EC50 = 1.46 μM. |
17950604 |
MCF7 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MCF7 cells assessed as cell viability by tryptan blue staining method, EC50 = 0.96 μM. |
17950604 |
Fb |
Cytotoxicity assay |
|
|
Cytotoxicity against human Fb cells assessed as cell viability by tryptan blue staining method, EC50 = 0.93 μM. |
17950604 |
A549 |
Cytotoxicity assay |
|
|
Cytotoxicity against human A549 cells assessed as cell viability by tryptan blue staining method, EC50 = 0.43 μM. |
17950604 |
PC3 |
Cytotoxicity assay |
|
|
Cytotoxicity against human PC3 cells assessed as cell viability by tryptan blue staining method, EC50 = 0.14 μM. |
17950604 |
KATO III |
Cytotoxicity assay |
|
|
Cytotoxicity against human KATO III cells by MTT assay, ED50 = 49 μM. |
12880314 |
SCL6 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SCL6 cells by MTT assay, ED50 = 20.7 μM. |
12880314 |
SCL |
Cytotoxicity assay |
|
|
Cytotoxicity against human SCL cells by MTT assay, ED50 = 20.2 μM. |
12880314 |
NUGC4 |
Cytotoxicity assay |
|
|
Cytotoxicity against human NUGC4 cells by MTT assay, ED50 = 19.1 μM. |
12880314 |
SCL37'6 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SCL37'6 cells by MTT assay, ED50 = 19 μM. |
12880314 |
SCL9 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SCL9 cells by MTT assay, ED50 = 17.4 μM. |
12880314 |
K562 |
Function assay |
|
|
In vitro inhibitory activity against K562 leukemia cells in the presence of pd2, IC50 = 0.0158 μM. |
12699386 |
K562 |
Function assay |
|
|
In vitro inhibitory activity against K562 leukemia cells, IC50 = 0.001 μM. |
12699386 |
colon cancer cell |
Cytotoxicity assay |
|
|
Cytotoxicity against human colon cancer cells, GI50 = 0.18 μM. |
11473418 |
ovarian cancer cell |
Cytotoxicity assay |
|
|
Cytotoxicity against human ovarian cancer cells, GI50 = 0.12 μM. |
11473418 |
stomach cancer cell |
Cytotoxicity assay |
|
|
Cytotoxicity against human stomach cancer cells, GI50 = 0.1 μM. |
11473418 |
CNS cancer cell |
Cytotoxicity assay |
|
|
Cytotoxicity against human CNS cancer cells, GI50 = 0.064 μM. |
11473418 |
breast cancer cell |
Cytotoxicity assay |
|
|
Cytotoxicity against human breast cancer cells, GI50 = 0.034 μM. |
11473418 |
lung cancer cell |
Cytotoxicity assay |
|
|
Cytotoxicity against human lung cancer cells, GI50 = 0.023 μM. |
11473418 |
MCF-7 |
Antiproliferative assay |
|
|
Antiproliferative activity of compound was evaluated on MCF-7 cells from human breast adenocarcinoma, ID50 = 42.92 μM. |
11012027 |
Molt3 |
Antiproliferative assay |
|
|
Antiproliferative activity of compound was evaluated on Molt3 cells from human lymphoblastic leukemia, ID50 = 2.66 μM. |
11012027 |
SupT1 |
Antiproliferative assay |
|
|
Antiproliferative activity of compound was evaluated on SupT1 cells from human non-Hodgkin lymphoma, ID50 = 0.7 μM. |
11012027 |
aerobic cell |
Function assay |
|
|
In vitro concentration required to kill 50% of the aerobic cells, C50 = 0.8 μM. |
9240349 |
V79-379A |
Function assay |
|
|
In vitro concentration required to kill hypoxic cells V79-379A cells, C50 = 0.4 μM. |
9240349 |
DC-3F/AD-II |
Growth inhibition assay |
|
|
Inhibition of cell growth was studied in chinese hamster lung cells resistant to actinomycin D (DC-3F/AD-II)., IC50 = 0.11 μM. |
8709111 |
DC-3F |
Growth inhibition assay |
|
|
Inhibition of cell growth was studied in chinese hamster lung cells (DC-3F), IC50 = 0.082 μM. |
8709111 |
HL-60 |
Growth inhibition assay |
|
|
Inhibition of cell growth was studied in human promyelocytic leukemic (HL-60) cells., IC50 = 0.05 μM. |
8709111 |
P388 |
Function assay |
|
|
Evaluation of inhibitory activity against multidrug resistant P388 cells (P388/ADR) cells, IC50 = 0.535 μM. |
8544183 |
P388 |
Function assay |
|
|
Evaluation of inhibitory activity against drug sensitive P388 cells (P388/S) cells, IC50 = 0.048 μM. |
8544183 |
HeLa S3 |
Function assay |
|
|
In vitro anticellular activity against HeLa S3 cells, IC50 = 0.59 μM. |
8021919 |
HeLa S3 |
Function assay |
|
|
In vitro anticellular activity against HeLa S3 cells; 0.82-1.4, IC50 = 1.4 μM. |
8021918 |
HeLa S3 |
Function assay |
|
|
In vitro anticellular activity against HeLa S3 cells; 0.59-1.1, IC50 = 1.1 μM. |
8021918 |
V79 |
Function assay |
|
|
Inhibitory concentration required to kill 50% of the cells was evaluated under aerobic conditions from chinese hamster V79 cells., IC50 = 0.8 μM. |
7966141 |
V79 |
Function assay |
|
|
Inhibitory concentration required to kill 50% of the cells was evaluated under anaerobic (N2) conditions from chinese hamster V79 cells., IC50 = 0.4 μM. |
7966141 |
P388 |
Antitumor assay |
|
|
Antitumor potency on P388 leukemia cells in culture, IC50 = 0.0508 μM. |
1906109 |
L1210 |
Function assay |
|
|
Inhibitory concentration on multidrug-resistant L1210 leukemia cells., IC50 = 1.5 μM. |
1906107 |
L1210 |
Function assay |
|
|
Inhibitory concentration on parentral (sensitive) L1210 leukemia cells., IC50 = 0.09 μM. |
1906107 |
HeLa |
Function assay |
|
|
In vitro anticellular activity against HeLa cells., IC50 = 0.81 μM. |
1495011 |
WiDr colon cancer cell |
Growth inhibition assay |
|
|
In vitro inhibition of WiDr colon cancer cell line, IC50=10 nM |
1920349 |
SW480 colon cancer cell |
Growth inhibition assay |
|
|
In vitro inhibition of SW480 colon cancer cell line, IC50=7 nM |
1920349 |
human A2780 (ovarian) tumor cell |
Cytotoxic?assay |
|
|
The compound was evaluated for the cytotoxicity against human A2780 (ovarian) tumor cell lines, IC50=50 nM |
10698444 |
human HT-29 (colon) tumor cell |
Cytotoxic?assay |
|
|
The compound was evaluated for the cytotoxicity against human HT-29 (colon) tumor cell lines, IC50=40 nM |
10698444 |
human CH1 (ovarian) tumor cell |
Cytotoxic?assay |
|
|
The compound was evaluated for the cytotoxicity against human CH1 (ovarian) tumor cell lines, IC50=40 nM |
10698444 |
A549 |
Cytotoxicity assay |
|
|
Cytotoxicity against human A549 cells by MTT assay, IC50 = 3 μM. |
22545792 |
A549 |
Cytotoxicity assay |
|
|
Cytotoxicity against human A549 cells, IC50 = 0.5 μM. |
27089214 |
PC3 |
Cytotoxicity assay |
|
|
Cytotoxicity against human PC3 cells, IC50 = 0.5 μM. |
27089214 |
NTERA-S-cl-D1 |
Growth inhibition assay |
|
|
IC50 = 0.0221 nM |
SANGER |
MOLT-4 |
Growth inhibition assay |
|
|
IC50 = 0.0325 nM |
SANGER |
J82 |
Growth inhibition assay |
|
|
IC50 = 0.119 nM |
SANGER |
697 |
Growth inhibition assay |
|
|
IC50 = 0.1283 nM |
SANGER |
KYSE-510 |
Growth inhibition assay |
|
|
IC50 = 0.1486 nM |
SANGER |
NCI-H2170 |
Growth inhibition assay |
|
|
IC50 = 0.1513 nM |
SANGER |
BE-13 |
Growth inhibition assay |
|
|
IC50 = 0.1673 nM |
SANGER |
LC-2-ad |
Growth inhibition assay |
|
|
IC50 = 0.2492 nM |
SANGER |
IMR-5 |
Growth inhibition assay |
|
|
IC50 = 0.3076 nM |
SANGER |
EW-16 |
Growth inhibition assay |
|
|
IC50 = 0.31 nM |
SANGER |
MC-IXC |
Growth inhibition assay |
|
|
IC50 = 0.638 nM |
SANGER |
SW872 |
Growth inhibition assay |
|
|
IC50 = 0.676 nM |
SANGER |
NCI-H2228 |
Growth inhibition assay |
|
|
IC50 = 0.7963 nM |
SANGER |
NALM-6 |
Growth inhibition assay |
|
|
IC50 = 1.066 nM |
SANGER |
ES4 |
Growth inhibition assay |
|
|
IC50 = 1.555 nM |
SANGER |
KE-37 |
Growth inhibition assay |
|
|
IC50 = 1.636 nM |
SANGER |
IST-MEL1 |
Growth inhibition assay |
|
|
IC50 = 1.684 nM |
SANGER |
ES8 |
Growth inhibition assay |
|
|
IC50 = 1.712 nM |
SANGER |
MV-4-11 |
Growth inhibition assay |
|
|
IC50 = 1.732 nM |
SANGER |
639-V |
Growth inhibition assay |
|
|
IC50 = 1.759 nM |
SANGER |
OCI-AML2 |
Growth inhibition assay |
|
|
IC50 = 1.886 nM |
SANGER |
SK-LU-1 |
Growth inhibition assay |
|
|
IC50 = 2.217 nM |
SANGER |
REH |
Growth inhibition assay |
|
|
IC50 = 2.548 nM |
SANGER |
PSN1 |
Growth inhibition assay |
|
|
IC50 = 2.554 nM |
SANGER |
SBC-5 |
Growth inhibition assay |
|
|
IC50 = 2.589 nM |
SANGER |
HT-3 |
Growth inhibition assay |
|
|
IC50 = 2.928 nM |
SANGER |
SIG-M5 |
Growth inhibition assay |
|
|
IC50 = 3.524 nM |
SANGER |
ES7 |
Growth inhibition assay |
|
|
IC50 = 3.653 nM |
SANGER |
CHP-212 |
Growth inhibition assay |
|
|
IC50 = 4.368 nM |
SANGER |
P12-ICHIKAWA |
Growth inhibition assay |
|
|
IC50 = 4.787 nM |
SANGER |
HUTU-80 |
Growth inhibition assay |
|
|
IC50 = 4.83 nM |
SANGER |
P30-OHK |
Growth inhibition assay |
|
|
IC50 = 4.842 nM |
SANGER |
NCI-H1651 |
Growth inhibition assay |
|
|
IC50 = 4.99 nM |
SANGER |
COR-L279 |
Growth inhibition assay |
|
|
IC50 = 5.545 nM |
SANGER |
CMK |
Growth inhibition assay |
|
|
IC50 = 5.827 nM |
SANGER |
MHH-CALL-2 |
Growth inhibition assay |
|
|
IC50 = 6.06 nM |
SANGER |
BV-173 |
Growth inhibition assay |
|
|
IC50 = 6.067 nM |
SANGER |
NCI-H209 |
Growth inhibition assay |
|
|
IC50 = 6.168 nM |
SANGER |
NCI-H460 |
Growth inhibition assay |
|
|
IC50 = 6.452 nM |
SANGER |
DU-145 |
Growth inhibition assay |
|
|
IC50 = 6.519 nM |
SANGER |
769-P |
Growth inhibition assay |
|
|
IC50 = 7.112 nM |
SANGER |
ES1 |
Growth inhibition assay |
|
|
IC50 = 7.288 nM |
SANGER |
COLO-668 |
Growth inhibition assay |
|
|
IC50 = 7.545 nM |
SANGER |
NKM-1 |
Growth inhibition assay |
|
|
IC50 = 7.831 nM |
SANGER |
ES3 |
Growth inhibition assay |
|
|
IC50 = 7.882 nM |
SANGER |
SCC-3 |
Growth inhibition assay |
|
|
IC50 = 8.519 nM |
SANGER |
SU-DHL-1 |
Growth inhibition assay |
|
|
IC50 = 8.609 nM |
SANGER |
ML-2 |
Growth inhibition assay |
|
|
IC50 = 8.781 nM |
SANGER |
SF295 |
Growth inhibition assay |
|
|
IC50 = 11.48 nM |
SANGER |
EW-7 |
Growth inhibition assay |
|
|
IC50 = 12.14 nM |
SANGER |
H4 |
Growth inhibition assay |
|
|
IC50 = 12.44 nM |
SANGER |
LB2241-RCC |
Growth inhibition assay |
|
|
IC50 = 13.19 nM |
SANGER |
SR |
Growth inhibition assay |
|
|
IC50 = 13.46 nM |
SANGER |
LB1047-RCC |
Growth inhibition assay |
|
|
IC50 = 13.6 nM |
SANGER |
MCF7 |
Growth inhibition assay |
|
|
IC50 = 13.9 nM |
SANGER |
ESS-1 |
Growth inhibition assay |
|
|
IC50 = 13.92 nM |
SANGER |
NCI-H2122 |
Growth inhibition assay |
|
|
IC50 = 13.96 nM |
SANGER |
786-0 |
Growth inhibition assay |
|
|
IC50 = 14.01 nM |
SANGER |
COLO-205 |
Growth inhibition assay |
|
|
IC50 = 14.33 nM |
SANGER |
HAL-01 |
Growth inhibition assay |
|
|
IC50 = 15.73 nM |
SANGER |
MHH-ES-1 |
Growth inhibition assay |
|
|
IC50 = 16.26 nM |
SANGER |
NUGC-3 |
Growth inhibition assay |
|
|
IC50 = 16.95 nM |
SANGER |
RPMI-8402 |
Growth inhibition assay |
|
|
IC50 = 17.13 nM |
SANGER |
ATN-1 |
Growth inhibition assay |
|
|
IC50 = 17.39 nM |
SANGER |
NCI-H441 |
Growth inhibition assay |
|
|
IC50 = 17.6 nM |
SANGER |
LB996-RCC |
Growth inhibition assay |
|
|
IC50 = 17.68 nM |
SANGER |
CAL-148 |
Growth inhibition assay |
|
|
IC50 = 17.83 nM |
SANGER |
CTV-1 |
Growth inhibition assay |
|
|
IC50 = 18.67 nM |
SANGER |
HOP-62 |
Growth inhibition assay |
|
|
IC50 = 20.2 nM |
SANGER |
CAKI-1 |
Growth inhibition assay |
|
|
IC50 = 23.32 nM |
SANGER |
PA-1 |
Growth inhibition assay |
|
|
IC50 = 23.51 nM |
SANGER |
HT-144 |
Growth inhibition assay |
|
|
IC50 = 23.75 nM |
SANGER |
LOUCY |
Growth inhibition assay |
|
|
IC50 = 26.19 nM |
SANGER |
BPH-1 |
Growth inhibition assay |
|
|
IC50 = 29.9 nM |
SANGER |
LS-1034 |
Growth inhibition assay |
|
|
IC50 = 30.16 nM |
SANGER |
23132-87 |
Growth inhibition assay |
|
|
IC50 = 30.53 nM |
SANGER |
BB30-HNC |
Growth inhibition assay |
|
|
IC50 = 30.61 nM |
SANGER |
CAL-51 |
Growth inhibition assay |
|
|
IC50 = 30.86 nM |
SANGER |
ALL-PO |
Growth inhibition assay |
|
|
IC50 = 30.98 nM |
SANGER |
5637 |
Growth inhibition assay |
|
|
IC50 = 31.93 nM |
SANGER |
KYSE-150 |
Growth inhibition assay |
|
|
IC50 = 34.09 nM |
SANGER |
RS4-11 |
Growth inhibition assay |
|
|
IC50 = 34.86 nM |
SANGER |
A3-KAW |
Growth inhibition assay |
|
|
IC50 = 34.96 nM |
SANGER |
NCI-H719 |
Growth inhibition assay |
|
|
IC50 = 35.12 nM |
SANGER |
GI-1 |
Growth inhibition assay |
|
|
IC50 = 35.16 nM |
SANGER |
HEL |
Growth inhibition assay |
|
|
IC50 = 35.8 nM |
SANGER |
TE-8 |
Growth inhibition assay |
|
|
IC50 = 35.86 nM |
SANGER |
HT-29 |
Growth inhibition assay |
|
|
IC50 = 36.02 nM |
SANGER |
SW1783 |
Growth inhibition assay |
|
|
IC50 = 38.58 nM |
SANGER |
CGTH-W-1 |
Growth inhibition assay |
|
|
IC50 = 38.74 nM |
SANGER |
MEL-HO |
Growth inhibition assay |
|
|
IC50 = 39.4 nM |
SANGER |
SW620 |
Growth inhibition assay |
|
|
IC50 = 39.79 nM |
SANGER |
ME-180 |
Growth inhibition assay |
|
|
IC50 = 40.11 nM |
SANGER |
CAL-27 |
Growth inhibition assay |
|
|
IC50 = 41.18 nM |
SANGER |
A431 |
Growth inhibition assay |
|
|
IC50 = 43.77 nM |
SANGER |
SW954 |
Growth inhibition assay |
|
|
IC50 = 44.91 nM |
SANGER |
CAL-39 |
Growth inhibition assay |
|
|
IC50 = 46.49 nM |
SANGER |
LU-134-A |
Growth inhibition assay |
|
|
IC50 = 46.72 nM |
SANGER |
DU-4475 |
Growth inhibition assay |
|
|
IC50 = 47.47 nM |
SANGER |
DEL |
Growth inhibition assay |
|
|
IC50 = 48.39 nM |
SANGER |
HGC-27 |
Growth inhibition assay |
|
|
IC50 = 49.29 nM |
SANGER |
RH-1 |
Growth inhibition assay |
|
|
IC50 = 49.57 nM |
SANGER |
SK-MES-1 |
Growth inhibition assay |
|
|
IC50 = 51.12 nM |
SANGER |
MEL-JUSO |
Growth inhibition assay |
|
|
IC50 = 51.25 nM |
SANGER |
VA-ES-BJ |
Growth inhibition assay |
|
|
IC50 = 52.16 nM |
SANGER |
EW-13 |
Growth inhibition assay |
|
|
IC50 = 52.51 nM |
SANGER |
Ca-Ski |
Growth inhibition assay |
|
|
IC50 = 53.75 nM |
SANGER |
LXF-289 |
Growth inhibition assay |
|
|
IC50 = 55.37 nM |
SANGER |
IM-9 |
Growth inhibition assay |
|
|
IC50 = 56.22 nM |
SANGER |
HCE-4 |
Growth inhibition assay |
|
|
IC50 = 57.94 nM |
SANGER |
TYK-nu |
Growth inhibition assay |
|
|
IC50 = 58.73 nM |
SANGER |
NCI-H748 |
Growth inhibition assay |
|
|
IC50 = 59.54 nM |
SANGER |
ABC-1 |
Growth inhibition assay |
|
|
IC50 = 61.2 nM |
SANGER |
CCRF-CEM |
Growth inhibition assay |
|
|
IC50 = 61.68 nM |
SANGER |
EW-3 |
Growth inhibition assay |
|
|
IC50 = 61.95 nM |
SANGER |
NCI-H2342 |
Growth inhibition assay |
|
|
IC50 = 62.51 nM |
SANGER |
SK-PN-DW |
Growth inhibition assay |
|
|
IC50 = 63.76 nM |
SANGER |
EB2 |
Growth inhibition assay |
|
|
IC50 = 65.36 nM |
SANGER |
CAL-85-1 |
Growth inhibition assay |
|
|
IC50 = 65.88 nM |
SANGER |
NCI-H526 |
Growth inhibition assay |
|
|
IC50 = 67.37 nM |
SANGER |
MFH-ino |
Growth inhibition assay |
|
|
IC50 = 70.61 nM |
SANGER |
ACHN |
Growth inhibition assay |
|
|
IC50 = 72.08 nM |
SANGER |
MONO-MAC-6 |
Growth inhibition assay |
|
|
IC50 = 72.35 nM |
SANGER |
CHP-126 |
Growth inhibition assay |
|
|
IC50 = 72.44 nM |
SANGER |
SW1710 |
Growth inhibition assay |
|
|
IC50 = 72.58 nM |
SANGER |
TE-10 |
Growth inhibition assay |
|
|
IC50 = 72.6 nM |
SANGER |
TE-15 |
Growth inhibition assay |
|
|
IC50 = 73.7 nM |
SANGER |
PANC-10-05 |
Growth inhibition assay |
|
|
IC50 = 73.75 nM |
SANGER |
BHY |
Growth inhibition assay |
|
|
IC50 = 75.28 nM |
SANGER |
HSC-3 |
Growth inhibition assay |
|
|
IC50 = 75.54 nM |
SANGER |
COLO-800 |
Growth inhibition assay |
|
|
IC50 = 78.66 nM |
SANGER |
NB10 |
Growth inhibition assay |
|
|
IC50 = 81.65 nM |
SANGER |
SK-UT-1 |
Growth inhibition assay |
|
|
IC50 = 82.8 nM |
SANGER |
HSC-2 |
Growth inhibition assay |
|
|
IC50 = 83.42 nM |
SANGER |
GP5d |
Growth inhibition assay |
|
|
IC50 = 84 nM |
SANGER |
A204 |
Growth inhibition assay |
|
|
IC50 = 84.19 nM |
SANGER |
BFTC-909 |
Growth inhibition assay |
|
|
IC50 = 85.27 nM |
SANGER |
NCI-H2087 |
Growth inhibition assay |
|
|
IC50 = 85.69 nM |
SANGER |
G-402 |
Growth inhibition assay |
|
|
IC50 = 85.92 nM |
SANGER |
647-V |
Growth inhibition assay |
|
|
IC50 = 87.39 nM |
SANGER |
Daoy |
Growth inhibition assay |
|
|
IC50 = 88.01 nM |
SANGER |
EW-1 |
Growth inhibition assay |
|
|
IC50 = 88.07 nM |
SANGER |
BC-1 |
Growth inhibition assay |
|
|
IC50 = 88.81 nM |
SANGER |
OAW-42 |
Growth inhibition assay |
|
|
IC50 = 89.42 nM |
SANGER |
COLO-679 |
Growth inhibition assay |
|
|
IC50 = 90.25 nM |
SANGER |
TE-11 |
Growth inhibition assay |
|
|
IC50 = 91.77 nM |
SANGER |
BFTC-905 |
Growth inhibition assay |
|
|
IC50 = 92.69 nM |
SANGER |
KP-4 |
Growth inhibition assay |
|
|
IC50 = 93.15 nM |
SANGER |
DOHH-2 |
Growth inhibition assay |
|
|
IC50 = 93.83 nM |
SANGER |
L-540 |
Growth inhibition assay |
|
|
IC50 = 95.14 nM |
SANGER |
DSH1 |
Growth inhibition assay |
|
|
IC50 = 96.53 nM |
SANGER |
M059J |
Growth inhibition assay |
|
|
IC50 = 100.6 nM |
SANGER |
UM-UC-3 |
Growth inhibition assay |
|
|
IC50 = 101.83 nM |
SANGER |
ES5 |
Growth inhibition assay |
|
|
IC50 = 102.42 nM |
SANGER |
KYSE-270 |
Growth inhibition assay |
|
|
IC50 = 102.84 nM |
SANGER |
OCUB-M |
Growth inhibition assay |
|
|
IC50 = 102.98 nM |
SANGER |
C-4-II |
Growth inhibition assay |
|
|
IC50 = 103.51 nM |
SANGER |
BOKU |
Growth inhibition assay |
|
|
IC50 = 103.78 nM |
SANGER |
8-MG-BA |
Growth inhibition assay |
|
|
IC50 = 104 nM |
SANGER |
SW982 |
Growth inhibition assay |
|
|
IC50 = 104.73 nM |
SANGER |
AGS |
Growth inhibition assay |
|
|
IC50 = 105.8 nM |
SANGER |
IGROV-1 |
Growth inhibition assay |
|
|
IC50 = 105.97 nM |
SANGER |
HL-60 |
Growth inhibition assay |
|
|
IC50 = 106.06 nM |
SANGER |
A2780 |
Growth inhibition assay |
|
|
IC50 = 106.63 nM |
SANGER |
HOS |
Growth inhibition assay |
|
|
IC50 = 106.7 nM |
SANGER |
HuP-T4 |
Growth inhibition assay |
|
|
IC50 = 108.1 nM |
SANGER |
ETK-1 |
Growth inhibition assay |
|
|
IC50 = 108.24 nM |
SANGER |
IA-LM |
Growth inhibition assay |
|
|
IC50 = 108.63 nM |
SANGER |
MRK-nu-1 |
Growth inhibition assay |
|
|
IC50 = 110.25 nM |
SANGER |
SUP-T1 |
Growth inhibition assay |
|
|
IC50 = 110.4 nM |
SANGER |
A2058 |
Growth inhibition assay |
|
|
IC50 = 115.1 nM |
SANGER |
CAPAN-1 |
Growth inhibition assay |
|
|
IC50 = 116.4 nM |
SANGER |
NCI-H1355 |
Growth inhibition assay |
|
|
IC50 = 116.8 nM |
SANGER |
NCI-H1618 |
Growth inhibition assay |
|
|
IC50 = 117.76 nM |
SANGER |
QIMR-WIL |
Growth inhibition assay |
|
|
IC50 = 119.58 nM |
SANGER |
HCC1599 |
Growth inhibition assay |
|
|
IC50 = 120.17 nM |
SANGER |
GR-ST |
Growth inhibition assay |
|
|
IC50 = 121.34 nM |
SANGER |
G-361 |
Growth inhibition assay |
|
|
IC50 = 123.93 nM |
SANGER |
RKO |
Growth inhibition assay |
|
|
IC50 = 125.29 nM |
SANGER |
NCI-H1437 |
Growth inhibition assay |
|
|
IC50 = 126.26 nM |
SANGER |
SF539 |
Growth inhibition assay |
|
|
IC50 = 127.02 nM |
SANGER |
ACN |
Growth inhibition assay |
|
|
IC50 = 127.91 nM |
SANGER |
FADU |
Growth inhibition assay |
|
|
IC50 = 128.29 nM |
SANGER |
U251 |
Growth inhibition assay |
|
|
IC50 = 128.73 nM |
SANGER |
KALS-1 |
Growth inhibition assay |
|
|
IC50 = 129.14 nM |
SANGER |
KM-H2 |
Growth inhibition assay |
|
|
IC50 = 130.45 nM |
SANGER |
SJSA-1 |
Growth inhibition assay |
|
|
IC50 = 131.56 nM |
SANGER |
TE-5 |
Growth inhibition assay |
|
|
IC50 = 132.24 nM |
SANGER |
SNG-M |
Growth inhibition assay |
|
|
IC50 = 134.17 nM |
SANGER |
HCC1806 |
Growth inhibition assay |
|
|
IC50 = 134.54 nM |
SANGER |
NCI-H1734 |
Growth inhibition assay |
|
|
IC50 = 136.85 nM |
SANGER |
LCLC-97TM1 |
Growth inhibition assay |
|
|
IC50 = 138.72 nM |
SANGER |
NH-12 |
Growth inhibition assay |
|
|
IC50 = 139.13 nM |
SANGER |
A375 |
Growth inhibition assay |
|
|
IC50 = 139.42 nM |
SANGER |
NCI-SNU-5 |
Growth inhibition assay |
|
|
IC50 = 141.21 nM |
SANGER |
SK-OV-3 |
Growth inhibition assay |
|
|
IC50 = 142.64 nM |
SANGER |
22RV1 |
Growth inhibition assay |
|
|
IC50 = 144.07 nM |
SANGER |
SW1573 |
Growth inhibition assay |
|
|
IC50 = 144.68 nM |
SANGER |
BB65-RCC |
Growth inhibition assay |
|
|
IC50 = 144.71 nM |
SANGER |
MES-SA |
Growth inhibition assay |
|
|
IC50 = 144.94 nM |
SANGER |
K052 |
Growth inhibition assay |
|
|
IC50 = 149.34 nM |
SANGER |
KU812 |
Growth inhibition assay |
|
|
IC50 = 149.96 nM |
SANGER |
NOMO-1 |
Growth inhibition assay |
|
|
IC50 = 151.41 nM |
SANGER |
Ca9-22 |
Growth inhibition assay |
|
|
IC50 = 155.57 nM |
SANGER |
8305C |
Growth inhibition assay |
|
|
IC50 = 155.75 nM |
SANGER |
NCI-SNU-1 |
Growth inhibition assay |
|
|
IC50 = 156.24 nM |
SANGER |
HC-1 |
Growth inhibition assay |
|
|
IC50 = 156.51 nM |
SANGER |
SW962 |
Growth inhibition assay |
|
|
IC50 = 157.55 nM |
SANGER |
HCC2998 |
Growth inhibition assay |
|
|
IC50 = 160.13 nM |
SANGER |
DMS-273 |
Growth inhibition assay |
|
|
IC50 = 160.83 nM |
SANGER |
MC-CAR |
Growth inhibition assay |
|
|
IC50 = 160.91 nM |
SANGER |
Caov-3 |
Growth inhibition assay |
|
|
IC50 = 161.72 nM |
SANGER |
EoL-1-cell |
Growth inhibition assay |
|
|
IC50 = 162.39 nM |
SANGER |
MKN45 |
Growth inhibition assay |
|
|
IC50 = 165.04 nM |
SANGER |
TE-1 |
Growth inhibition assay |
|
|
IC50 = 165.38 nM |
SANGER |
HMV-II |
Growth inhibition assay |
|
|
IC50 = 166.06 nM |
SANGER |
SK-NEP-1 |
Growth inhibition assay |
|
|
IC50 = 166.53 nM |
SANGER |
PANC-03-27 |
Growth inhibition assay |
|
|
IC50 = 167.16 nM |
SANGER |
RPMI-7951 |
Growth inhibition assay |
|
|
IC50 = 167.55 nM |
SANGER |
NCI-H520 |
Growth inhibition assay |
|
|
IC50 = 168.65 nM |
SANGER |
NCI-H522 |
Growth inhibition assay |
|
|
IC50 = 169.45 nM |
SANGER |
Detroit562 |
Growth inhibition assay |
|
|
IC50 = 170.26 nM |
SANGER |
SF268 |
Growth inhibition assay |
|
|
IC50 = 170.86 nM |
SANGER |
T84 |
Growth inhibition assay |
|
|
IC50 = 173.34 nM |
SANGER |
NB69 |
Growth inhibition assay |
|
|
IC50 = 175.06 nM |
SANGER |
OVCAR-8 |
Growth inhibition assay |
|
|
IC50 = 175.54 nM |
SANGER |
RT-112 |
Growth inhibition assay |
|
|
IC50 = 177.98 nM |
SANGER |
DoTc2-4510 |
Growth inhibition assay |
|
|
IC50 = 180.37 nM |
SANGER |
J-RT3-T3-5 |
Growth inhibition assay |
|
|
IC50 = 185.8 nM |
SANGER |
NB1 |
Growth inhibition assay |
|
|
IC50 = 186.61 nM |
SANGER |
NEC8 |
Growth inhibition assay |
|
|
IC50 = 186.77 nM |
SANGER |
TUR |
Growth inhibition assay |
|
|
IC50 = 189.67 nM |
SANGER |
TE-12 |
Growth inhibition assay |
|
|
IC50 = 189.83 nM |
SANGER |
WSU-NHL |
Growth inhibition assay |
|
|
IC50 = 192.04 nM |
SANGER |
MHH-NB-11 |
Growth inhibition assay |
|
|
IC50 = 192.55 nM |
SANGER |
SW48 |
Growth inhibition assay |
|
|
IC50 = 193.36 nM |
SANGER |
C3A |
Growth inhibition assay |
|
|
IC50 = 194.31 nM |
SANGER |
RPMI-2650 |
Growth inhibition assay |
|
|
IC50 = 195.75 nM |
SANGER |
VMRC-RCZ |
Growth inhibition assay |
|
|
IC50 = 198.77 nM |
SANGER |
SK-CO-1 |
Growth inhibition assay |
|
|
IC50 = 0.20181 μM |
SANGER |
KYSE-180 |
Growth inhibition assay |
|
|
IC50 = 0.20219 μM |
SANGER |
KGN |
Growth inhibition assay |
|
|
IC50 = 0.20713 μM |
SANGER |
A388 |
Growth inhibition assay |
|
|
IC50 = 0.20722 μM |
SANGER |
NCI-H2030 |
Growth inhibition assay |
|
|
IC50 = 0.21132 μM |
SANGER |
NCI-H727 |
Growth inhibition assay |
|
|
IC50 = 0.2118 μM |
SANGER |
BC-3 |
Growth inhibition assay |
|
|
IC50 = 0.21208 μM |
SANGER |
CCF-STTG1 |
Growth inhibition assay |
|
|
IC50 = 0.21559 μM |
SANGER |
NMC-G1 |
Growth inhibition assay |
|
|
IC50 = 0.21675 μM |
SANGER |
NCI-H1299 |
Growth inhibition assay |
|
|
IC50 = 0.21841 μM |
SANGER |
RPMI-6666 |
Growth inhibition assay |
|
|
IC50 = 0.21961 μM |
SANGER |
D-283MED |
Growth inhibition assay |
|
|
IC50 = 0.22069 μM |
SANGER |
AM-38 |
Growth inhibition assay |
|
|
IC50 = 0.22116 μM |
SANGER |
LU-99A |
Growth inhibition assay |
|
|
IC50 = 0.22424 μM |
SANGER |
KYSE-70 |
Growth inhibition assay |
|
|
IC50 = 0.22431 μM |
SANGER |
CHL-1 |
Growth inhibition assay |
|
|
IC50 = 0.22516 μM |
SANGER |
CESS |
Growth inhibition assay |
|
|
IC50 = 0.2254 μM |
SANGER |
A4-Fuk |
Growth inhibition assay |
|
|
IC50 = 0.22543 μM |
SANGER |
MG-63 |
Growth inhibition assay |
|
|
IC50 = 0.22618 μM |
SANGER |
MKN28 |
Growth inhibition assay |
|
|
IC50 = 0.23009 μM |
SANGER |
NCI-H1417 |
Growth inhibition assay |
|
|
IC50 = 0.2369 μM |
SANGER |
BCPAP |
Growth inhibition assay |
|
|
IC50 = 0.2396 μM |
SANGER |
COR-L23 |
Growth inhibition assay |
|
|
IC50 = 0.24094 μM |
SANGER |
SIMA |
Growth inhibition assay |
|
|
IC50 = 0.24142 μM |
SANGER |
CAL-62 |
Growth inhibition assay |
|
|
IC50 = 0.24185 μM |
SANGER |
ARH-77 |
Growth inhibition assay |
|
|
IC50 = 0.24331 μM |
SANGER |
COLO-680N |
Growth inhibition assay |
|
|
IC50 = 0.2441 μM |
SANGER |
T-24 |
Growth inhibition assay |
|
|
IC50 = 0.24577 μM |
SANGER |
PF-382 |
Growth inhibition assay |
|
|
IC50 = 0.25063 μM |
SANGER |
NCI-H810 |
Growth inhibition assay |
|
|
IC50 = 0.25161 μM |
SANGER |
NCI-H1882 |
Growth inhibition assay |
|
|
IC50 = 0.25709 μM |
SANGER |
A101D |
Growth inhibition assay |
|
|
IC50 = 0.25745 μM |
SANGER |
NCI-H2126 |
Growth inhibition assay |
|
|
IC50 = 0.2602 μM |
SANGER |
VM-CUB-1 |
Growth inhibition assay |
|
|
IC50 = 0.26082 μM |
SANGER |
OS-RC-2 |
Growth inhibition assay |
|
|
IC50 = 0.2637 μM |
SANGER |
MIA-PaCa-2 |
Growth inhibition assay |
|
|
IC50 = 0.27545 μM |
SANGER |
SW837 |
Growth inhibition assay |
|
|
IC50 = 0.27613 μM |
SANGER |
NCI-H358 |
Growth inhibition assay |
|
|
IC50 = 0.27626 μM |
SANGER |
NCI-H1703 |
Growth inhibition assay |
|
|
IC50 = 0.27688 μM |
SANGER |
NCI-H1650 |
Growth inhibition assay |
|
|
IC50 = 0.28257 μM |
SANGER |
SW626 |
Growth inhibition assay |
|
|
IC50 = 0.28622 μM |
SANGER |
MFE-296 |
Growth inhibition assay |
|
|
IC50 = 0.28623 μM |
SANGER |
NCI-H2009 |
Growth inhibition assay |
|
|
IC50 = 0.28857 μM |
SANGER |
NCI-H2405 |
Growth inhibition assay |
|
|
IC50 = 0.29434 μM |
SANGER |
BL-41 |
Growth inhibition assay |
|
|
IC50 = 0.2949 μM |
SANGER |
SNU-C2B |
Growth inhibition assay |
|
|
IC50 = 0.29505 μM |
SANGER |
no-10 |
Growth inhibition assay |
|
|
IC50 = 0.2996 μM |
SANGER |
A427 |
Growth inhibition assay |
|
|
IC50 = 0.30133 μM |
SANGER |
SNB75 |
Growth inhibition assay |
|
|
IC50 = 0.30346 μM |
SANGER |
CTB-1 |
Growth inhibition assay |
|
|
IC50 = 0.30637 μM |
SANGER |
BT-20 |
Growth inhibition assay |
|
|
IC50 = 0.31197 μM |
SANGER |
GT3TKB |
Growth inhibition assay |
|
|
IC50 = 0.31823 μM |
SANGER |
COR-L88 |
Growth inhibition assay |
|
|
IC50 = 0.31914 μM |
SANGER |
Calu-6 |
Growth inhibition assay |
|
|
IC50 = 0.31971 μM |
SANGER |
Calu-3 |
Growth inhibition assay |
|
|
IC50 = 0.32095 μM |
SANGER |
IGR-1 |
Growth inhibition assay |
|
|
IC50 = 0.3216 μM |
SANGER |
LS-411N |
Growth inhibition assay |
|
|
IC50 = 0.32176 μM |
SANGER |
LAN-6 |
Growth inhibition assay |
|
|
IC50 = 0.32779 μM |
SANGER |
ONS-76 |
Growth inhibition assay |
|
|
IC50 = 0.32956 μM |
SANGER |
MZ7-mel |
Growth inhibition assay |
|
|
IC50 = 0.33256 μM |
SANGER |
LB647-SCLC |
Growth inhibition assay |
|
|
IC50 = 0.33608 μM |
SANGER |
OE33 |
Growth inhibition assay |
|
|
IC50 = 0.3378 μM |
SANGER |
NCI-H1770 |
Growth inhibition assay |
|
|
IC50 = 0.34265 μM |
SANGER |
MS-1 |
Growth inhibition assay |
|
|
IC50 = 0.34402 μM |
SANGER |
NCI-H650 |
Growth inhibition assay |
|
|
IC50 = 0.34407 μM |
SANGER |
MDA-MB-468 |
Growth inhibition assay |
|
|
IC50 = 0.34531 μM |
SANGER |
A253 |
Growth inhibition assay |
|
|
IC50 = 0.34564 μM |
SANGER |
LOXIMVI |
Growth inhibition assay |
|
|
IC50 = 0.3525 μM |
SANGER |
BB49-HNC |
Growth inhibition assay |
|
|
IC50 = 0.35252 μM |
SANGER |
HT-1080 |
Growth inhibition assay |
|
|
IC50 = 0.35371 μM |
SANGER |
NB5 |
Growth inhibition assay |
|
|
IC50 = 0.3579 μM |
SANGER |
LK-2 |
Growth inhibition assay |
|
|
IC50 = 0.35814 μM |
SANGER |
KS-1 |
Growth inhibition assay |
|
|
IC50 = 0.36415 μM |
SANGER |
OE19 |
Growth inhibition assay |
|
|
IC50 = 0.36496 μM |
SANGER |
U031 |
Growth inhibition assay |
|
|
IC50 = 0.3658 μM |
SANGER |
HCE-T |
Growth inhibition assay |
|
|
IC50 = 0.37153 μM |
SANGER |
NCI-H1304 |
Growth inhibition assay |
|
|
IC50 = 0.37523 μM |
SANGER |
SKG-IIIa |
Growth inhibition assay |
|
|
IC50 = 0.37738 μM |
SANGER |
GDM-1 |
Growth inhibition assay |
|
|
IC50 = 0.37746 μM |
SANGER |
CPC-N |
Growth inhibition assay |
|
|
IC50 = 0.38066 μM |
SANGER |
KYSE-140 |
Growth inhibition assay |
|
|
IC50 = 0.38134 μM |
SANGER |
SH-4 |
Growth inhibition assay |
|
|
IC50 = 0.38726 μM |
SANGER |
IST-SL2 |
Growth inhibition assay |
|
|
IC50 = 0.38762 μM |
SANGER |
SCC-4 |
Growth inhibition assay |
|
|
IC50 = 0.3877 μM |
SANGER |
OMC-1 |
Growth inhibition assay |
|
|
IC50 = 0.38955 μM |
SANGER |
Daudi |
Growth inhibition assay |
|
|
IC50 = 0.39242 μM |
SANGER |
JVM-2 |
Growth inhibition assay |
|
|
IC50 = 0.39734 μM |
SANGER |
NCI-H510A |
Growth inhibition assay |
|
|
IC50 = 0.40282 μM |
SANGER |
NCI-H1838 |
Growth inhibition assay |
|
|
IC50 = 0.40419 μM |
SANGER |
GCIY |
Growth inhibition assay |
|
|
IC50 = 0.41099 μM |
SANGER |
NCI-H747 |
Growth inhibition assay |
|
|
IC50 = 0.41159 μM |
SANGER |
NCI-H1694 |
Growth inhibition assay |
|
|
IC50 = 0.41528 μM |
SANGER |
UACC-893 |
Growth inhibition assay |
|
|
IC50 = 0.41801 μM |
SANGER |
DMS-153 |
Growth inhibition assay |
|
|
IC50 = 0.42526 μM |
SANGER |
GAMG |
Growth inhibition assay |
|
|
IC50 = 0.42821 μM |
SANGER |
LB373-MEL-D |
Growth inhibition assay |
|
|
IC50 = 0.42962 μM |
SANGER |
8505C |
Growth inhibition assay |
|
|
IC50 = 0.42983 μM |
SANGER |
DB |
Growth inhibition assay |
|
|
IC50 = 0.42995 μM |
SANGER |
LoVo |
Growth inhibition assay |
|
|
IC50 = 0.43068 μM |
SANGER |
MZ2-MEL |
Growth inhibition assay |
|
|
IC50 = 0.43247 μM |
SANGER |
L-363 |
Growth inhibition assay |
|
|
IC50 = 0.43417 μM |
SANGER |
HSC-4 |
Growth inhibition assay |
|
|
IC50 = 0.43445 μM |
SANGER |
NCI-N87 |
Growth inhibition assay |
|
|
IC50 = 0.43812 μM |
SANGER |
SK-LMS-1 |
Growth inhibition assay |
|
|
IC50 = 0.43929 μM |
SANGER |
HO-1-N-1 |
Growth inhibition assay |
|
|
IC50 = 0.44064 μM |
SANGER |
OAW-28 |
Growth inhibition assay |
|
|
IC50 = 0.44065 μM |
SANGER |
SBC-1 |
Growth inhibition assay |
|
|
IC50 = 0.4477 μM |
SANGER |
LNCaP-Clone-FGC |
Growth inhibition assay |
|
|
IC50 = 0.45008 μM |
SANGER |
MZ1-PC |
Growth inhibition assay |
|
|
IC50 = 0.45011 μM |
SANGER |
GB-1 |
Growth inhibition assay |
|
|
IC50 = 0.45218 μM |
SANGER |
LCLC-103H |
Growth inhibition assay |
|
|
IC50 = 0.46087 μM |
SANGER |
YT |
Growth inhibition assay |
|
|
IC50 = 0.46333 μM |
SANGER |
HCT-15 |
Growth inhibition assay |
|
|
IC50 = 0.46462 μM |
SANGER |
CaR-1 |
Growth inhibition assay |
|
|
IC50 = 0.46878 μM |
SANGER |
SK-MEL-30 |
Growth inhibition assay |
|
|
IC50 = 0.47431 μM |
SANGER |
TCCSUP |
Growth inhibition assay |
|
|
IC50 = 0.4817 μM |
SANGER |
C-33-A |
Growth inhibition assay |
|
|
IC50 = 0.48687 μM |
SANGER |
OVCAR-5 |
Growth inhibition assay |
|
|
IC50 = 0.48711 μM |
SANGER |
CAL-12T |
Growth inhibition assay |
|
|
IC50 = 0.49125 μM |
SANGER |
PC-14 |
Growth inhibition assay |
|
|
IC50 = 0.49127 μM |
SANGER |
ST486 |
Growth inhibition assay |
|
|
IC50 = 0.49436 μM |
SANGER |
HLE |
Growth inhibition assay |
|
|
IC50 = 0.49832 μM |
SANGER |
TE-9 |
Growth inhibition assay |
|
|
IC50 = 0.50049 μM |
SANGER |
AU565 |
Growth inhibition assay |
|
|
IC50 = 0.50096 μM |
SANGER |
LU-165 |
Growth inhibition assay |
|
|
IC50 = 0.51311 μM |
SANGER |
EW-11 |
Growth inhibition assay |
|
|
IC50 = 0.51336 μM |
SANGER |
FTC-133 |
Growth inhibition assay |
|
|
IC50 = 0.51722 μM |
SANGER |
NCI-H1648 |
Growth inhibition assay |
|
|
IC50 = 0.52301 μM |
SANGER |
AN3-CA |
Growth inhibition assay |
|
|
IC50 = 0.52328 μM |
SANGER |
KURAMOCHI |
Growth inhibition assay |
|
|
IC50 = 0.52344 μM |
SANGER |
T98G |
Growth inhibition assay |
|
|
IC50 = 0.52375 μM |
SANGER |
TK10 |
Growth inhibition assay |
|
|
IC50 = 0.52832 μM |
SANGER |
LB2518-MEL |
Growth inhibition assay |
|
|
IC50 = 0.53456 μM |
SANGER |
CAL-33 |
Growth inhibition assay |
|
|
IC50 = 0.53653 μM |
SANGER |
A172 |
Growth inhibition assay |
|
|
IC50 = 0.53752 μM |
SANGER |
D-263MG |
Growth inhibition assay |
|
|
IC50 = 0.54004 μM |
SANGER |
CAMA-1 |
Growth inhibition assay |
|
|
IC50 = 0.54059 μM |
SANGER |
MKN1 |
Growth inhibition assay |
|
|
IC50 = 0.54081 μM |
SANGER |
NCI-H661 |
Growth inhibition assay |
|
|
IC50 = 0.54158 μM |
SANGER |
YKG-1 |
Growth inhibition assay |
|
|
IC50 = 0.545 μM |
SANGER |
GOTO |
Growth inhibition assay |
|
|
IC50 = 0.55371 μM |
SANGER |
KYSE-450 |
Growth inhibition assay |
|
|
IC50 = 0.56311 μM |
SANGER |
UMC-11 |
Growth inhibition assay |
|
|
IC50 = 0.56701 μM |
SANGER |
DBTRG-05MG |
Growth inhibition assay |
|
|
IC50 = 0.57026 μM |
SANGER |
KYSE-410 |
Growth inhibition assay |
|
|
IC50 = 0.58359 μM |
SANGER |
MOLT-16 |
Growth inhibition assay |
|
|
IC50 = 0.58519 μM |
SANGER |
HCC2218 |
Growth inhibition assay |
|
|
IC50 = 0.58882 μM |
SANGER |
EFO-21 |
Growth inhibition assay |
|
|
IC50 = 0.59114 μM |
SANGER |
S-117 |
Growth inhibition assay |
|
|
IC50 = 0.59244 μM |
SANGER |
HCC1937 |
Growth inhibition assay |
|
|
IC50 = 0.59382 μM |
SANGER |
THP-1 |
Growth inhibition assay |
|
|
IC50 = 0.5955 μM |
SANGER |
GAK |
Growth inhibition assay |
|
|
IC50 = 0.59624 μM |
SANGER |
SW756 |
Growth inhibition assay |
|
|
IC50 = 0.59691 μM |
SANGER |
KG-1 |
Growth inhibition assay |
|
|
IC50 = 0.59714 μM |
SANGER |
D-542MG |
Growth inhibition assay |
|
|
IC50 = 0.60165 μM |
SANGER |
HCC38 |
Growth inhibition assay |
|
|
IC50 = 0.60411 μM |
SANGER |
SAS |
Growth inhibition assay |
|
|
IC50 = 0.61465 μM |
SANGER |
RVH-421 |
Growth inhibition assay |
|
|
IC50 = 0.62917 μM |
SANGER |
JiyoyeP-2003 |
Growth inhibition assay |
|
|
IC50 = 0.62954 μM |
SANGER |
G-401 |
Growth inhibition assay |
|
|
IC50 = 0.63447 μM |
SANGER |
SW1990 |
Growth inhibition assay |
|
|
IC50 = 0.63705 μM |
SANGER |
KP-N-YS |
Growth inhibition assay |
|
|
IC50 = 0.64012 μM |
SANGER |
HD-MY-Z |
Growth inhibition assay |
|
|
IC50 = 0.64025 μM |
SANGER |
LAMA-84 |
Growth inhibition assay |
|
|
IC50 = 0.64166 μM |
SANGER |
SW13 |
Growth inhibition assay |
|
|
IC50 = 0.64249 μM |
SANGER |
HCC1569 |
Growth inhibition assay |
|
|
IC50 = 0.64461 μM |
SANGER |
CP66-MEL |
Growth inhibition assay |
|
|
IC50 = 0.64495 μM |
SANGER |
SK-HEP-1 |
Growth inhibition assay |
|
|
IC50 = 0.64566 μM |
SANGER |
NB13 |
Growth inhibition assay |
|
|
IC50 = 0.64603 μM |
SANGER |
NY |
Growth inhibition assay |
|
|
IC50 = 0.65739 μM |
SANGER |
EHEB |
Growth inhibition assay |
|
|
IC50 = 0.67213 μM |
SANGER |
MEG-01 |
Growth inhibition assay |
|
|
IC50 = 0.68336 μM |
SANGER |
HCC70 |
Growth inhibition assay |
|
|
IC50 = 0.69433 μM |
SANGER |
OVCAR-4 |
Growth inhibition assay |
|
|
IC50 = 0.69691 μM |
SANGER |
NCI-H1792 |
Growth inhibition assay |
|
|
IC50 = 0.69734 μM |
SANGER |
HEC-1 |
Growth inhibition assay |
|
|
IC50 = 0.69824 μM |
SANGER |
NCI-H187 |
Growth inhibition assay |
|
|
IC50 = 0.70799 μM |
SANGER |
TGBC24TKB |
Growth inhibition assay |
|
|
IC50 = 0.71 μM |
SANGER |
HuP-T3 |
Growth inhibition assay |
|
|
IC50 = 0.71055 μM |
SANGER |
SK-MEL-3 |
Growth inhibition assay |
|
|
IC50 = 0.71112 μM |
SANGER |
MDA-MB-415 |
Growth inhibition assay |
|
|
IC50 = 0.72395 μM |
SANGER |
HCC2157 |
Growth inhibition assay |
|
|
IC50 = 0.72685 μM |
SANGER |
NCI-H2081 |
Growth inhibition assay |
|
|
IC50 = 0.74057 μM |
SANGER |
ES6 |
Growth inhibition assay |
|
|
IC50 = 0.74562 μM |
SANGER |
KYSE-520 |
Growth inhibition assay |
|
|
IC50 = 0.77218 μM |
SANGER |
BxPC-3 |
Growth inhibition assay |
|
|
IC50 = 0.77478 μM |
SANGER |
NCI-H226 |
Growth inhibition assay |
|
|
IC50 = 0.77721 μM |
SANGER |
LB771-HNC |
Growth inhibition assay |
|
|
IC50 = 0.77974 μM |
SANGER |
CP50-MEL-B |
Growth inhibition assay |
|
|
IC50 = 0.78003 μM |
SANGER |
HN |
Growth inhibition assay |
|
|
IC50 = 0.78254 μM |
SANGER |
EW-24 |
Growth inhibition assay |
|
|
IC50 = 0.78297 μM |
SANGER |
A673 |
Growth inhibition assay |
|
|
IC50 = 0.7896 μM |
SANGER |
COLO-684 |
Growth inhibition assay |
|
|
IC50 = 0.7993 μM |
SANGER |
DMS-53 |
Growth inhibition assay |
|
|
IC50 = 0.80856 μM |
SANGER |
MDA-MB-361 |
Growth inhibition assay |
|
|
IC50 = 0.80898 μM |
SANGER |
SNU-475 |
Growth inhibition assay |
|
|
IC50 = 0.81314 μM |
SANGER |
LB831-BLC |
Growth inhibition assay |
|
|
IC50 = 0.81608 μM |
SANGER |
RCM-1 |
Growth inhibition assay |
|
|
IC50 = 0.84728 μM |
SANGER |
NCI-H2347 |
Growth inhibition assay |
|
|
IC50 = 0.84997 μM |
SANGER |
NCI-H2141 |
Growth inhibition assay |
|
|
IC50 = 0.85281 μM |
SANGER |
Becker |
Growth inhibition assay |
|
|
IC50 = 0.86232 μM |
SANGER |
LC-1F |
Growth inhibition assay |
|
|
IC50 = 0.86233 μM |
SANGER |
SCC-15 |
Growth inhibition assay |
|
|
IC50 = 0.86386 μM |
SANGER |
U-266 |
Growth inhibition assay |
|
|
IC50 = 0.86618 μM |
SANGER |
SCC-25 |
Growth inhibition assay |
|
|
IC50 = 0.87036 μM |
SANGER |
NCI-H1155 |
Growth inhibition assay |
|
|
IC50 = 0.87336 μM |
SANGER |
NCI-H292 |
Growth inhibition assay |
|
|
IC50 = 0.88441 μM |
SANGER |
NCI-H2196 |
Growth inhibition assay |
|
|
IC50 = 0.886 μM |
SANGER |
EKVX |
Growth inhibition assay |
|
|
IC50 = 0.893 μM |
SANGER |
TE-6 |
Growth inhibition assay |
|
|
IC50 = 0.89367 μM |
SANGER |
NCI-H1693 |
Growth inhibition assay |
|
|
IC50 = 0.89963 μM |
SANGER |
HuCCT1 |
Growth inhibition assay |
|
|
IC50 = 0.90351 μM |
SANGER |
NCI-H1581 |
Growth inhibition assay |
|
|
IC50 = 0.90674 μM |
SANGER |
KARPAS-422 |
Growth inhibition assay |
|
|
IC50 = 0.90739 μM |
SANGER |
C8166 |
Growth inhibition assay |
|
|
IC50 = 0.93232 μM |
SANGER |
BEN |
Growth inhibition assay |
|
|
IC50 = 0.93516 μM |
SANGER |
SCLC-21H |
Growth inhibition assay |
|
|
IC50 = 0.96303 μM |
SANGER |
HT-1376 |
Growth inhibition assay |
|
|
IC50 = 0.96711 μM |
SANGER |
NCI-H1963 |
Growth inhibition assay |
|
|
IC50 = 0.97437 μM |
SANGER |
MPP-89 |
Growth inhibition assay |
|
|
IC50 = 0.99122 μM |
SANGER |
SW1417 |
Growth inhibition assay |
|
|
IC50 = 1.00545 μM |
SANGER |
NCCIT |
Growth inhibition assay |
|
|
IC50 = 1.01024 μM |
SANGER |
MMAC-SF |
Growth inhibition assay |
|
|
IC50 = 1.01163 μM |
SANGER |
LU-65 |
Growth inhibition assay |
|
|
IC50 = 1.01247 μM |
SANGER |
NCI-H1623 |
Growth inhibition assay |
|
|
IC50 = 1.01428 μM |
SANGER |
HCT-116 |
Growth inhibition assay |
|
|
IC50 = 1.01502 μM |
SANGER |
CA46 |
Growth inhibition assay |
|
|
IC50 = 1.0198 μM |
SANGER |
RERF-LC-MS |
Growth inhibition assay |
|
|
IC50 = 1.03157 μM |
SANGER |
DJM-1 |
Growth inhibition assay |
|
|
IC50 = 1.03304 μM |
SANGER |
EM-2 |
Growth inhibition assay |
|
|
IC50 = 1.03374 μM |
SANGER |
HCC1395 |
Growth inhibition assay |
|
|
IC50 = 1.05754 μM |
SANGER |
HCC1143 |
Growth inhibition assay |
|
|
IC50 = 1.0664 μM |
SANGER |
HH |
Growth inhibition assay |
|
|
IC50 = 1.0738 μM |
SANGER |
MDA-MB-453 |
Growth inhibition assay |
|
|
IC50 = 1.07917 μM |
SANGER |
COLO-320-HSR |
Growth inhibition assay |
|
|
IC50 = 1.0792 μM |
SANGER |
KM12 |
Growth inhibition assay |
|
|
IC50 = 1.08364 μM |
SANGER |
KNS-42 |
Growth inhibition assay |
|
|
IC50 = 1.09239 μM |
SANGER |
HPAF-II |
Growth inhibition assay |
|
|
IC50 = 1.09715 μM |
SANGER |
OVCAR-3 |
Growth inhibition assay |
|
|
IC50 = 1.12787 μM |
SANGER |
EFO-27 |
Growth inhibition assay |
|
|
IC50 = 1.13122 μM |
SANGER |
L-428 |
Growth inhibition assay |
|
|
IC50 = 1.15778 μM |
SANGER |
LS-513 |
Growth inhibition assay |
|
|
IC50 = 1.17808 μM |
SANGER |
NB12 |
Growth inhibition assay |
|
|
IC50 = 1.20371 μM |
SANGER |
NCI-H23 |
Growth inhibition assay |
|
|
IC50 = 1.20661 μM |
SANGER |
TGBC1TKB |
Growth inhibition assay |
|
|
IC50 = 1.21141 μM |
SANGER |
LU-139 |
Growth inhibition assay |
|
|
IC50 = 1.21841 μM |
SANGER |
Raji |
Growth inhibition assay |
|
|
IC50 = 1.22094 μM |
SANGER |
IPC-298 |
Growth inhibition assay |
|
|
IC50 = 1.22841 μM |
SANGER |
NCI-H838 |
Growth inhibition assay |
|
|
IC50 = 1.23291 μM |
SANGER |
RPMI-8226 |
Growth inhibition assay |
|
|
IC50 = 1.23847 μM |
SANGER |
LC4-1 |
Growth inhibition assay |
|
|
IC50 = 1.23959 μM |
SANGER |
MN-60 |
Growth inhibition assay |
|
|
IC50 = 1.26332 μM |
SANGER |
U-87-MG |
Growth inhibition assay |
|
|
IC50 = 1.27372 μM |
SANGER |
BL-70 |
Growth inhibition assay |
|
|
IC50 = 1.27667 μM |
SANGER |
MLMA |
Growth inhibition assay |
|
|
IC50 = 1.30978 μM |
SANGER |
RPMI-8866 |
Growth inhibition assay |
|
|
IC50 = 1.31777 μM |
SANGER |
M14 |
Growth inhibition assay |
|
|
IC50 = 1.3376 μM |
SANGER |
RCC10RGB |
Growth inhibition assay |
|
|
IC50 = 1.34936 μM |
SANGER |
SK-MEL-24 |
Growth inhibition assay |
|
|
IC50 = 1.37423 μM |
SANGER |
SHP-77 |
Growth inhibition assay |
|
|
IC50 = 1.3783 μM |
SANGER |
EFE-184 |
Growth inhibition assay |
|
|
IC50 = 1.38125 μM |
SANGER |
GI-ME-N |
Growth inhibition assay |
|
|
IC50 = 1.39089 μM |
SANGER |
SF126 |
Growth inhibition assay |
|
|
IC50 = 1.40565 μM |
SANGER |
Saos-2 |
Growth inhibition assay |
|
|
IC50 = 1.40649 μM |
SANGER |
KARPAS-299 |
Growth inhibition assay |
|
|
IC50 = 1.41651 μM |
SANGER |
MC116 |
Growth inhibition assay |
|
|
IC50 = 1.41664 μM |
SANGER |
NCI-H1563 |
Growth inhibition assay |
|
|
IC50 = 1.42784 μM |
SANGER |
COLO-824 |
Growth inhibition assay |
|
|
IC50 = 1.44461 μM |
SANGER |
IST-SL1 |
Growth inhibition assay |
|
|
IC50 = 1.4462 μM |
SANGER |
HDLM-2 |
Growth inhibition assay |
|
|
IC50 = 1.4601 μM |
SANGER |
NCI-H1573 |
Growth inhibition assay |
|
|
IC50 = 1.46085 μM |
SANGER |
NCI-H2171 |
Growth inhibition assay |
|
|
IC50 = 1.49785 μM |
SANGER |
NOS-1 |
Growth inhibition assay |
|
|
IC50 = 1.50227 μM |
SANGER |
COLO-792 |
Growth inhibition assay |
|
|
IC50 = 1.50264 μM |
SANGER |
SNU-423 |
Growth inhibition assay |
|
|
IC50 = 1.52181 μM |
SANGER |
C32 |
Growth inhibition assay |
|
|
IC50 = 1.52834 μM |
SANGER |
KOSC-2 |
Growth inhibition assay |
|
|
IC50 = 1.53103 μM |
SANGER |
NCI-H64 |
Growth inhibition assay |
|
|
IC50 = 1.53444 μM |
SANGER |
HT |
Growth inhibition assay |
|
|
IC50 = 1.53659 μM |
SANGER |
NCI-H596 |
Growth inhibition assay |
|
|
IC50 = 1.5377 μM |
SANGER |
NCI-H720 |
Growth inhibition assay |
|
|
IC50 = 1.54425 μM |
SANGER |
UACC-257 |
Growth inhibition assay |
|
|
IC50 = 1.56566 μM |
SANGER |
EVSA-T |
Growth inhibition assay |
|
|
IC50 = 1.57368 μM |
SANGER |
KNS-81-FD |
Growth inhibition assay |
|
|
IC50 = 1.59446 μM |
SANGER |
TE-441-T |
Growth inhibition assay |
|
|
IC50 = 1.60276 μM |
SANGER |
U-698-M |
Growth inhibition assay |
|
|
IC50 = 1.60291 μM |
SANGER |
COR-L105 |
Growth inhibition assay |
|
|
IC50 = 1.61317 μM |
SANGER |
KMOE-2 |
Growth inhibition assay |
|
|
IC50 = 1.62413 μM |
SANGER |
KY821 |
Growth inhibition assay |
|
|
IC50 = 1.65078 μM |
SANGER |
SJRH30 |
Growth inhibition assay |
|
|
IC50 = 1.6742 μM |
SANGER |
NCI-H69 |
Growth inhibition assay |
|
|
IC50 = 1.67882 μM |
SANGER |
RT4 |
Growth inhibition assay |
|
|
IC50 = 1.69923 μM |
SANGER |
LS-123 |
Growth inhibition assay |
|
|
IC50 = 1.72001 μM |
SANGER |
BHT-101 |
Growth inhibition assay |
|
|
IC50 = 1.74029 μM |
SANGER |
K5 |
Growth inhibition assay |
|
|
IC50 = 1.78398 μM |
SANGER |
SK-N-AS |
Growth inhibition assay |
|
|
IC50 = 1.79073 μM |
SANGER |
NCI-H322M |
Growth inhibition assay |
|
|
IC50 = 1.80152 μM |
SANGER |
NCI-H1793 |
Growth inhibition assay |
|
|
IC50 = 1.81482 μM |
SANGER |
CAL-54 |
Growth inhibition assay |
|
|
IC50 = 1.84148 μM |
SANGER |
SK-MEL-1 |
Growth inhibition assay |
|
|
IC50 = 1.88815 μM |
SANGER |
SiHa |
Growth inhibition assay |
|
|
IC50 = 1.8934 μM |
SANGER |
RD |
Growth inhibition assay |
|
|
IC50 = 1.89846 μM |
SANGER |
ChaGo-K-1 |
Growth inhibition assay |
|
|
IC50 = 1.91033 μM |
SANGER |
SNU-C1 |
Growth inhibition assay |
|
|
IC50 = 1.914 μM |
SANGER |
NCI-H1436 |
Growth inhibition assay |
|
|
IC50 = 1.92742 μM |
SANGER |
HOP-92 |
Growth inhibition assay |
|
|
IC50 = 1.93658 μM |
SANGER |
HT55 |
Growth inhibition assay |
|
|
IC50 = 1.95457 μM |
SANGER |
K-562 |
Growth inhibition assay |
|
|
IC50 = 1.97869 μM |
SANGER |
NCI-H2052 |
Growth inhibition assay |
|
|
IC50 = 1.98812 μM |
SANGER |
HT-1197 |
Growth inhibition assay |
|
|
IC50 = 2.02174 μM |
SANGER |
SW1463 |
Growth inhibition assay |
|
|
IC50 = 2.08169 μM |
SANGER |
COLO-829 |
Growth inhibition assay |
|
|
IC50 = 2.08684 μM |
SANGER |
DMS-114 |
Growth inhibition assay |
|
|
IC50 = 2.08692 μM |
SANGER |
EFM-19 |
Growth inhibition assay |
|
|
IC50 = 2.08896 μM |
SANGER |
LN-405 |
Growth inhibition assay |
|
|
IC50 = 2.15428 μM |
SANGER |
UACC-62 |
Growth inhibition assay |
|
|
IC50 = 2.15533 μM |
SANGER |
MDA-MB-134-VI |
Growth inhibition assay |
|
|
IC50 = 2.1586 μM |
SANGER |
MDA-MB-157 |
Growth inhibition assay |
|
|
IC50 = 2.19254 μM |
SANGER |
COLO-741 |
Growth inhibition assay |
|
|
IC50 = 2.19928 μM |
SANGER |
JEG-3 |
Growth inhibition assay |
|
|
IC50 = 2.23191 μM |
SANGER |
NB6 |
Growth inhibition assay |
|
|
IC50 = 2.23352 μM |
SANGER |
NCI-H1395 |
Growth inhibition assay |
|
|
IC50 = 2.23483 μM |
SANGER |
KARPAS-45 |
Growth inhibition assay |
|
|
IC50 = 2.27184 μM |
SANGER |
HCC1954 |
Growth inhibition assay |
|
|
IC50 = 2.28119 μM |
SANGER |
A704 |
Growth inhibition assay |
|
|
IC50 = 2.38311 μM |
SANGER |
SK-N-DZ |
Growth inhibition assay |
|
|
IC50 = 2.38958 μM |
SANGER |
EGI-1 |
Growth inhibition assay |
|
|
IC50 = 2.39059 μM |
SANGER |
TALL-1 |
Growth inhibition assay |
|
|
IC50 = 2.3955 μM |
SANGER |
PANC-08-13 |
Growth inhibition assay |
|
|
IC50 = 2.39777 μM |
SANGER |
NCI-H28 |
Growth inhibition assay |
|
|
IC50 = 2.43524 μM |
SANGER |
DMS-79 |
Growth inhibition assay |
|
|
IC50 = 2.47163 μM |
SANGER |
NCI-H889 |
Growth inhibition assay |
|
|
IC50 = 2.48342 μM |
SANGER |
Ramos-2G6-4C10 |
Growth inhibition assay |
|
|
IC50 = 2.54572 μM |
SANGER |
BT-474 |
Growth inhibition assay |
|
|
IC50 = 2.62326 μM |
SANGER |
JVM-3 |
Growth inhibition assay |
|
|
IC50 = 2.64752 μM |
SANGER |
NCI-H524 |
Growth inhibition assay |
|
|
IC50 = 2.7032 μM |
SANGER |
SK-MM-2 |
Growth inhibition assay |
|
|
IC50 = 2.71695 μM |
SANGER |
TGW |
Growth inhibition assay |
|
|
IC50 = 2.75803 μM |
SANGER |
Capan-2 |
Growth inhibition assay |
|
|
IC50 = 2.78528 μM |
SANGER |
NCI-H82 |
Growth inhibition assay |
|
|
IC50 = 2.80193 μM |
SANGER |
NCI-H716 |
Growth inhibition assay |
|
|
IC50 = 2.82042 μM |
SANGER |
MSTO-211H |
Growth inhibition assay |
|
|
IC50 = 2.82369 μM |
SANGER |
COLO-678 |
Growth inhibition assay |
|
|
IC50 = 2.88691 μM |
SANGER |
AsPC-1 |
Growth inhibition assay |
|
|
IC50 = 2.89855 μM |
SANGER |
DV-90 |
Growth inhibition assay |
|
|
IC50 = 2.92143 μM |
SANGER |
SNU-387 |
Growth inhibition assay |
|
|
IC50 = 2.93467 μM |
SANGER |
KLE |
Growth inhibition assay |
|
|
IC50 = 2.98224 μM |
SANGER |
U-118-MG |
Growth inhibition assay |
|
|
IC50 = 3.14284 μM |
SANGER |
MHH-PREB-1 |
Growth inhibition assay |
|
|
IC50 = 3.14735 μM |
SANGER |
MDA-MB-175-VII |
Growth inhibition assay |
|
|
IC50 = 3.15819 μM |
SANGER |
EB-3 |
Growth inhibition assay |
|
|
IC50 = 3.19768 μM |
SANGER |
HuH-7 |
Growth inhibition assay |
|
|
IC50 = 3.22286 μM |
SANGER |
NCI-H1522 |
Growth inhibition assay |
|
|
IC50 = 3.23546 μM |
SANGER |
MDA-MB-231 |
Growth inhibition assay |
|
|
IC50 = 3.23964 μM |
SANGER |
NCI-H1092 |
Growth inhibition assay |
|
|
IC50 = 3.2799 μM |
SANGER |
KU-19-19 |
Growth inhibition assay |
|
|
IC50 = 3.35835 μM |
SANGER |
SNU-449 |
Growth inhibition assay |
|
|
IC50 = 3.36209 μM |
SANGER |
CAS-1 |
Growth inhibition assay |
|
|
IC50 = 3.38185 μM |
SANGER |
KP-N-YN |
Growth inhibition assay |
|
|
IC50 = 3.41535 μM |
SANGER |
P31-FUJ |
Growth inhibition assay |
|
|
IC50 = 3.45775 μM |
SANGER |
RMG-I |
Growth inhibition assay |
|
|
IC50 = 3.46127 μM |
SANGER |
SN12C |
Growth inhibition assay |
|
|
IC50 = 3.46177 μM |
SANGER |
HCC1419 |
Growth inhibition assay |
|
|
IC50 = 3.48402 μM |
SANGER |
TT |
Growth inhibition assay |
|
|
IC50 = 3.67775 μM |
SANGER |
SW948 |
Growth inhibition assay |
|
|
IC50 = 3.75281 μM |
SANGER |
SCC-9 |
Growth inhibition assay |
|
|
IC50 = 3.78753 μM |
SANGER |
KMS-12-PE |
Growth inhibition assay |
|
|
IC50 = 3.82788 μM |
SANGER |
GMS-10 |
Growth inhibition assay |
|
|
IC50 = 3.83807 μM |
SANGER |
EW-18 |
Growth inhibition assay |
|
|
IC50 = 3.9388 μM |
SANGER |
SK-MEL-2 |
Growth inhibition assay |
|
|
IC50 = 3.97464 μM |
SANGER |
PC-3 |
Growth inhibition assay |
|
|
IC50 = 4.07159 μM |
SANGER |
IST-MES1 |
Growth inhibition assay |
|
|
IC50 = 4.14621 μM |
SANGER |
PLC-PRF-5 |
Growth inhibition assay |
|
|
IC50 = 4.19446 μM |
SANGER |
YAPC |
Growth inhibition assay |
|
|
IC50 = 4.36751 μM |
SANGER |
RXF393 |
Growth inhibition assay |
|
|
IC50 = 4.38975 μM |
SANGER |
LP-1 |
Growth inhibition assay |
|
|
IC50 = 4.55967 μM |
SANGER |
JAR |
Growth inhibition assay |
|
|
IC50 = 4.56384 μM |
SANGER |
GCT |
Growth inhibition assay |
|
|
IC50 = 4.6047 μM |
SANGER |
SW1088 |
Growth inhibition assay |
|
|
IC50 = 4.66827 μM |
SANGER |
NCI-H345 |
Growth inhibition assay |
|
|
IC50 = 4.73193 μM |
SANGER |
Calu-1 |
Growth inhibition assay |
|
|
IC50 = 4.8072 μM |
SANGER |
ECC4 |
Growth inhibition assay |
|
|
IC50 = 5.07036 μM |
SANGER |
DOK |
Growth inhibition assay |
|
|
IC50 = 5.1551 μM |
SANGER |
RL |
Growth inhibition assay |
|
|
IC50 = 5.43657 μM |
SANGER |
NCI-H1755 |
Growth inhibition assay |
|
|
IC50 = 5.43694 μM |
SANGER |
HTC-C3 |
Growth inhibition assay |
|
|
IC50 = 5.78944 μM |
SANGER |
PFSK-1 |
Growth inhibition assay |
|
|
IC50 = 5.88351 μM |
SANGER |
CAL-120 |
Growth inhibition assay |
|
|
IC50 = 5.96351 μM |
SANGER |
Hs-578-T |
Growth inhibition assay |
|
|
IC50 = 6.20302 μM |
SANGER |
DG-75 |
Growth inhibition assay |
|
|
IC50 = 6.2494 μM |
SANGER |
NCI-H2227 |
Growth inhibition assay |
|
|
IC50 = 6.32364 μM |
SANGER |
OPM-2 |
Growth inhibition assay |
|
|
IC50 = 6.34857 μM |
SANGER |
T47D |
Growth inhibition assay |
|
|
IC50 = 6.37191 μM |
SANGER |
HuO-3N1 |
Growth inhibition assay |
|
|
IC50 = 6.45452 μM |
SANGER |
D-392MG |
Growth inhibition assay |
|
|
IC50 = 6.68451 μM |
SANGER |
NCI-SNU-16 |
Growth inhibition assay |
|
|
IC50 = 6.74309 μM |
SANGER |
CW-2 |
Growth inhibition assay |
|
|
IC50 = 7.72758 μM |
SANGER |
no-11 |
Growth inhibition assay |
|
|
IC50 = 7.74202 μM |
SANGER |
MFE-280 |
Growth inhibition assay |
|
|
IC50 = 8.34873 μM |
SANGER |
KINGS-1 |
Growth inhibition assay |
|
|
IC50 = 8.61164 μM |
SANGER |
HCC1187 |
Growth inhibition assay |
|
|
IC50 = 8.9213 μM |
SANGER |
NCI-H2452 |
Growth inhibition assay |
|
|
IC50 = 8.93628 μM |
SANGER |
C2BBe1 |
Growth inhibition assay |
|
|
IC50 = 9.284 μM |
SANGER |
Mewo |
Growth inhibition assay |
|
|
IC50 = 9.55233 μM |
SANGER |
MFM-223 |
Growth inhibition assay |
|
|
IC50 = 10.3807 μM |
SANGER |
NCI-H446 |
Growth inhibition assay |
|
|
IC50 = 12.4227 μM |
SANGER |
RO82-W-1 |
Growth inhibition assay |
|
|
IC50 = 13.3274 μM |
SANGER |
EC-GI-10 |
Growth inhibition assay |
|
|
IC50 = 14.9132 μM |
SANGER |
UACC-812 |
Growth inhibition assay |
|
|
IC50 = 16.8306 μM |
SANGER |
SK-MEL-28 |
Growth inhibition assay |
|
|
IC50 = 18.9731 μM |
SANGER |
DK-MG |
Growth inhibition assay |
|
|
IC50 = 21.667 μM |
SANGER |
NCI-H1993 |
Growth inhibition assay |
|
|
IC50 = 22.984 μM |
SANGER |
U-2-OS |
Growth inhibition assay |
|
|
IC50 = 23.6987 μM |
SANGER |
MKN7 |
Growth inhibition assay |
|
|
IC50 = 27.8562 μM |
SANGER |
SK-N-FI |
Growth inhibition assay |
|
|
IC50 = 39.7075 μM |
SANGER |
CAL-72 |
Growth inhibition assay |
|
|
IC50 = 46.7339 μM |
SANGER |